April 30, 2012European Journal of Heart Failure
Use of Implantable Cardioverter Defibrillators in Patients with Left Ventricular Assist Devices
Key result
Implantation of a primary prevention ICD after LVAD implantation is not supported by current evidence, poses potential risks, and requires clinical trials before becoming standard practice.
Population
Patients with left ventricular assist devices (LVADs)
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Does not support routine primary prevention ICDs after LVAD; leaves open whether RCTs can identify net benefit in selected patients.
Structured PICO
P
Population
Patients with left ventricular assist devices (LVADs)
I
Intervention
Implantable cardioverter defibrillators (ICDs) (reactivation of previously implanted devices or new primary prevention implantation)
Routine primary prevention ICD implantation after LVAD is not evidence-based and risks inappropriate shocks, highlighting the need for careful device programming and shared decision-making.
Cite This Study
Pettit et al. (2012) conducted a review in Patients with left ventricular assist devices (LVADs). Implantable Cardioverter Defibrillators (ICDs) was evaluated. Implantation of a primary prevention ICD after LVAD implantation is not supported by current evidence, poses potential risks, and requires clinical trials before becoming standard practice.